Cell Therapeutics, Inc. (Nasdaq: CTIC) has made a deal to sell $25.0 million of shares of its Series 8 Non-Convertible Preferred Stock (the "Series 8 Preferred Stock"), warrants to purchase up to 22,563,177 shares of common stock (the "Warrants") and an additional investment right (the...

Socius Capital Group, based in New York and Los Angeles, has made an investment of EUR16.1 million in Pharming Group NV (NYSE Euronext: PHARM). Socius has completed financings with numerous life sciences and other emerging growth companies in the United States and Europe.  Socius is adept...